¼¼°èÀÇ º¹¾à Áؼö ÀåÄ¡ ½ÃÀå º¸°í¼­(2025³â)
Medication Adherence Devices Global Market Report 2025
»óǰÄÚµå : 1769654
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,263,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,052,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,842,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¹¾à Áؼö ÀåÄ¡ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµÉ ¿¹Á¤ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀå Àü¸ÁÀº ¿¬°áÇü °Ç°­ ÀåÄ¡ÀÇ Ã¤Åà Áõ°¡, ¸ÂÃãÇü ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¿ø°Ý ÀÇ·á ¼­ºñ½ºÀÇ È®´ë, µðÁöÅÐ °Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ Áö¿øÀû ±ÔÁ¦ ȯ°æ, ÀÇ·á ºñ¿ë Àý°¨¿¡ ´ëÇÑ °­Á¶ °­È­ µî¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â »ç¹° ÀÎÅͳÝ(IoT) ÀåÄ¡ÀÇ ±â¼ú ¹ßÀü, º¹¾à Áؼö ¸ð´ÏÅ͸µÀ» À§ÇÑ Àΰø Áö´ÉÀÇ Çõ½Å, Ŭ¶ó¿ìµå ±â¹Ý µ¥ÀÌÅÍ ºÐ¼®ÀÇ ¹ßÀü, ½º¸¶Æ® ÆÐŰ¡¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß, ¿¹ÃøÀû º¹¿ë Áؼö ¼Ö·ç¼ÇÀ» À§ÇÑ ¸Ó½Å ·¯´×ÀÇ ÅëÇÕ µîÀÌ ÀÖ½À´Ï´Ù.

½ÉÇ÷°ü ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÇâÈÄ ¸î ³â µ¿¾È º¹¾à Áؼö ÀåÄ¡ ½ÃÀåÀÌ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀº ½ÉÀå°ú Ç÷°üÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ÁúȯÀ» Æ÷ÇÔÇϸç, ½É±Ù°æ»ö, ³úÁ¹Áß, ½ÉºÎÀü µî ½É°¢ÇÑ ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀÇ Áõ°¡¼¼´Â ÁÖ·Î ¾É¾Æ¼­ ÇÏ´Â »ýȰ ¹æ½ÄÀÇ È®»ê°ú °ü·ÃÀÌ ÀÖÀ¸¸ç, ¸¹Àº »ç¶÷µéÀÌ Àå½Ã°£ Ã¥»ó ¾Õ¿¡¼­ ÀÏÇÏ°í ½Åü Ȱµ¿ÀÌ ºÎÁ·ÇÑ »ýȰÀ» ¿µÀ§Çϰí ÀÖ½À´Ï´Ù. º¹¾à Áؼö ÀåÄ¡´Â ȯÀÚ°¡ ¾à¹°À» ÀϰüµÇ°Ô Á¤ÇØÁø ½Ã°£¿¡ º¹¿ëÇϵµ·Ï Áö¿øÇÔÀ¸·Î½á ½ÉÇ÷°ü Áúȯ °ü¸®¿¡ ±â¿©Çϸç, ºÎÀÛ¿ë À§ÇèÀ» ÁÙÀÌ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 1¿ù ¹Ì±¹ ½ÉÀå Çùȸ(¹Ì±¹ ±â¹Ý ºñ¿µ¸® ´Üü)´Â ½ÉÇ÷°ü ÁúȯÀ¸·Î ÀÎÇÑ ¿¬·É Á¶Á¤ »ç¸Á·üÀÌ 10¸¸ ¸í´ç 233.3¸íÀ¸·Î Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ´Â Àü³âµµ 10¸¸ ¸í´ç 224.4¸í ´ëºñ 4.0% Áõ°¡ÇÑ ¼öÄ¡·Î, Àü³âµµ¿¡´Â 4.6% Áõ°¡ÇÑ ¹Ù ÀÖ½À´Ï´Ù. ±× °á°ú, ½ÉÇ÷°ü ÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡Çϸ鼭 º¹¾à Áؼö ÀåÄ¡ÀÇ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

º¹¾à Áؼö ÀåÄ¡ ½ÃÀåÀÇ ¼±µµ ±â¾÷µéÀº º¹¾à Áؼö¸¦ ½Ç½Ã°£À¸·Î ¿ø°Ý ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ½º¸¶Æ® ¾Ë¾à Á¤¸®ÇÔ µî Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀÇ °³¹ßÀ» ¿ì¼± °úÁ¦·Î »ï°í ÀÖ½À´Ï´Ù. ½º¸¶Æ® ¾àǰ °ü¸®±â´Â »ç¿ëÀÚ°¡ ¾à¹°À» °ü¸®Çϵµ·Ï µ½±â À§ÇØ ÀÚµ¿ ¾Ë¸² Á¦°ø, ÀÏÁ¤´ë·Î ¾àǰ ºÐ¹è, ¸ð¹ÙÀÏ ¾Û°úÀÇ µ¿±âÈ­¸¦ ÅëÇØ ÃßÀû ¹× ¾Ë¸² ±â´ÉÀ» Á¦°øÇÏ´Â ÀüÀÚ ÀåÄ¡ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2025³â 4¿ù ¹Ì±¹ ±â¹Ý ó¹æ¾à ºÐ¹è ¿ë±â Á¦Á¶¾÷üÀÎ Centor Inc.´Â LTE ¹× Ŭ¶ó¿ìµå ±â¼úÀ» Ȱ¿ëÇÑ »õ·Î¿î ½º¸¶Æ® ÁÖ°£ ¾àǰ °ü¸®±â¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ÀåÄ¡´Â ¾à¹° º¹¿ëÀ» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÏ°í µ¥ÀÌÅ͸¦ ¾à±¹ ¹× ÀÓ»ó ÆÄÆ®³Ê¿¡°Ô Á÷Á¢ Àü¼ÛÇϹǷÎ, »ç¿ëÀÚ°¡ ½º¸¶Æ®Æù ¾ÛÀ» ´Ù¿î·ÎµåÇϰųª ¿¬°áÇÒ Çʿ䰡 ¾ø½À´Ï´Ù. À̴ ƯÈ÷ ³ëÀÎÀ̳ª ±â¼ú¿¡ Àͼ÷ÇÏÁö ¾ÊÀº »ç¶÷µé¿¡°Ô À¯¿ëÇÑ ±â´ÉÀÔ´Ï´Ù. RxCap°ú °øµ¿ °³¹ßµÈ ÀÌ ¾àÅëÀº »ç¿ëÀÚ Ä£È­ÀûÀ̸ç CentorÀÇ ¿ø°Ý ¸ð´ÏÅ͸µ ¼­ºñ½º¿Í ¿Ïº®ÇÏ°Ô ÅëÇյǾî, ¾à±¹ÀÌ È¯±Þ °¡´ÉÇÑ º¹¿ë Áؼö ÇÁ·Î±×·¥À» ±¸ÇöÇϰí Çʿ信 µû¶ó Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª 19 ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°, ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Medication adherence devices are specialized tools or technologies designed to assist patients in consistently following their prescribed medication regimens. These devices provide timely reminders, track medication usage, and, in some cases, automatically dispense doses to help prevent missed or incorrect intake, thereby enhancing treatment effectiveness and improving patient health outcomes.

The primary types of medication adherence devices include hardware-centric and software-centric solutions. Hardware-centric devices are physical tools such as smart pillboxes, automated dispensers, and specialized packaging systems that monitor medication intake and relay data to caregivers. These devices are used for managing various types of medications, including those for cardiovascular conditions, central nervous system disorders, diabetes, oncology, gastrointestinal issues, musculoskeletal problems, and others. They are utilized across different settings, including hospitals, homecare environments, pharmacies, long-term care facilities, and clinics.

The medication adherence devices market research report is one of a series of new reports from The Business Research Company that provides medication adherence devices market statistics, including medication adherence devices industry global market size, regional shares, competitors with a medication adherence devices market share, detailed medication adherence devices market segments, market trends and opportunities, and any further data you may need to thrive in the medication adherence devices industry. This medication adherence devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medication adherence devices market size has grown strongly in recent years. It will grow from $3.20 billion in 2024 to $3.40 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth during the historic period can be attributed to the rising prevalence of chronic diseases, an increasing geriatric population, heightened awareness of the importance of medication adherence, government efforts to minimize hospital readmissions, and the expansion of home healthcare services.

The medication adherence devices market size is expected to see strong growth in the next few years. It will grow to $4.32 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The projected growth in the forecast period can be attributed to the increasing adoption of connected health devices, rising demand for personalized healthcare, expansion of telehealth services, supportive regulatory frameworks for digital health solutions, and a growing emphasis on reducing healthcare costs. Key trends expected during this period include technological advancements in Internet of Things (IoT) devices, innovations in artificial intelligence for monitoring medication adherence, progress in cloud-based data analytics, ongoing research and development in smart packaging, and the integration of machine learning for predictive adherence solutions.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the medication adherence devices market in the coming years. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, often resulting in serious complications such as heart attacks, strokes, and heart failure. The rise in these conditions is largely attributed to more sedentary lifestyles, with many individuals spending prolonged hours in desk-based jobs and engaging in minimal physical activity. Medication adherence devices support the management of cardiovascular diseases by helping patients take their medications consistently and on schedule, thereby reducing the risk of adverse events. For example, in January 2024, the American Heart Association-a U.S.-based nonprofit organization-reported that the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000, representing a 4.0% rise from the previous year's rate of 224.4 per 100,000. This follows a 4.6% increase the year before. As a result, the growing burden of cardiovascular disease is fueling demand for medication adherence devices.

Leading companies in the medication adherence devices market are prioritizing the development of innovative solutions such as smart pill organizers to facilitate real-time remote monitoring of medication adherence. A smart pill organizer is an electronic device designed to help users manage their medications by offering automated reminders, dispensing pills at scheduled intervals, and syncing with mobile applications for tracking and alerts. For example, in April 2025, Centor Inc., a U.S.-based manufacturer of prescription medication dispensing containers, launched a new smart weekly pill organizer utilizing LTE and cloud technology to enhance medication adherence. This device monitors medication intake in real time and transmits data directly to pharmacies and clinical partners, removing the need for users to download or connect a smartphone app-an especially beneficial feature for elderly or less tech-savvy individuals. Co-developed with RxCap, the organizer is user-friendly and fully integrates with Centor's remote monitoring services, enabling pharmacies to implement reimbursable adherence programs and deliver timely interventions as needed.

In April 2024, Gerresheimer AG, a Germany-based manufacturer of drug delivery systems and medical devices, entered into a partnership with RxCap to provide connected adherence solutions. The goal of this collaboration is to enable pharmacies to deliver remote therapeutic monitoring services by leveraging smart packaging and cloud-based software, thereby enhancing medication management and improving patient health outcomes. RxCap Inc. is a U.S.-based healthcare technology company specializing in prescription adherence and remote therapeutic monitoring (RPM) solutions.

Major players in the medication adherence devices market are McKesson Corporation, Cardinal Health Inc., Johnson & Johnson Services Inc., Novartis AG, Becton Dickinson and Company, Koninklijke Philips N.V., AptarGroup Inc., Insulet Corporation, Omnicell Inc., Ypsomed Holding AG, MedMinder Systems Inc., Propeller Health Inc., Bigfoot Biomedical Inc., Information Mediary Corp., AARDEX Group SA, Hero Health Inc., CareRight Technologies, Adherium Limited, Popit Oy, SMRxT Inc., Wisepill Technologies Inc., and SeamlessMD.

North America was the largest region in the medication adherence devices market in 2024. The regions covered in medication adherence devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the medication adherence devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medication adherence devices market consists of revenues earned by entities by providing services, such as medication reminder services, remote monitoring services, refill reminders, customizable schedules, data analytics, and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The medication adherence devices market also includes sales of smart pill bottles, smart pill dispensers, connected inhalers, remote monitoring systems, and automatic pill crushers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medication Adherence Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medication adherence devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for medication adherence devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medication adherence devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Medication Adherence Devices Market Characteristics

3. Medication Adherence Devices Market Trends And Strategies

4. Medication Adherence Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Medication Adherence Devices Growth Analysis And Strategic Analysis Framework

6. Medication Adherence Devices Market Segmentation

7. Medication Adherence Devices Market Regional And Country Analysis

8. Asia-Pacific Medication Adherence Devices Market

9. China Medication Adherence Devices Market

10. India Medication Adherence Devices Market

11. Japan Medication Adherence Devices Market

12. Australia Medication Adherence Devices Market

13. Indonesia Medication Adherence Devices Market

14. South Korea Medication Adherence Devices Market

15. Western Europe Medication Adherence Devices Market

16. UK Medication Adherence Devices Market

17. Germany Medication Adherence Devices Market

18. France Medication Adherence Devices Market

19. Italy Medication Adherence Devices Market

20. Spain Medication Adherence Devices Market

21. Eastern Europe Medication Adherence Devices Market

22. Russia Medication Adherence Devices Market

23. North America Medication Adherence Devices Market

24. USA Medication Adherence Devices Market

25. Canada Medication Adherence Devices Market

26. South America Medication Adherence Devices Market

27. Brazil Medication Adherence Devices Market

28. Middle East Medication Adherence Devices Market

29. Africa Medication Adherence Devices Market

30. Medication Adherence Devices Market Competitive Landscape And Company Profiles

31. Medication Adherence Devices Market Other Major And Innovative Companies

32. Global Medication Adherence Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medication Adherence Devices Market

34. Recent Developments In The Medication Adherence Devices Market

35. Medication Adherence Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â